OPEN LABEL

Clinical trials for OPEN LABEL explained in plain language.

Never miss a new study

Get alerted when new OPEN LABEL trials appear

Sign up with your email to follow new studies for OPEN LABEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First patients to test new pill for Tough-to-Treat cancers

Disease control Recruiting now

This is the first study in people to test a new oral drug called FX-909. The main goals are to find a safe dose and see how well the body handles it, both alone and when combined with an existing immunotherapy drug (pembrolizumab). It is for adults with advanced solid tumors, inc…

Matched conditions: OPEN LABEL

Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

OPEN LABEL

Get alerted when new OPEN LABEL trials appear

First patients to test new pill for Tough-to-Treat cancers